Prevention of the Vertical Transmission of HIV; A Recap of the Journey so Far
Viruses · 26.03.2023 · 15 (4) · 849
DOI: 10.3390/v15040849 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 26.03.2023. Verfasst von Maria Camila Cardenas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Residency Program, Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Anti-HIV Agents, Pregnancy Complications, Infectious, HIV Infections. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
In 1989, one in four (25%) infants born to women living with HIV were infected; by the age of 2 years, there was 25% mortality among them due to HIV. These and other pieces of data prompted the development of interventions to offset vertical transmission, including the landmark Pediatric AIDS Clinical Trial Group Study (PACTG 076) in 1994. This study reported a 67.5% reduction in perinatal HIV transmission with prophylactic antenatal, intrapartum, and postnatal zidovudine. Numerous studies since then have provided compelling evidence to further optimize interventions, such that annual transmission rates of 0% are now reported by many health departments in the US and elimination has been validated in several countries around the world. Despite this success, the elimination of HIV’s vertical transmission on the global scale remains a work in progress, limited by socioeconomic factors such as the prohibitive cost of antiretrovirals. Here, we review some of the key trials underpinning the development of guidelines in the US as well as globally, and discuss the evidence through a historic lens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Residency Program, Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.
- Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.
- Pediatric Residency Program, Nicklaus Children's Hospital, 3100 SW 62nd Ave, Miami, FL 33155, USA.
- Maternal Fetal Medicine Division, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 33155, USA.
- Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA.
- Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA.
ORCID-Profile: Elizabeth Ann L Enninga, Regan Theiler, Clive M Gray, Rana Chakraborty
Förderung
- NICHD NIH HHS
Zitieren
APA
Cardenas, M. C., Farnan, S., Hamel, B. L., Mejia Plazas, M. C., Sintim-Aboagye, E., Littlefield, D. R., Behl, S., Punia, S., Enninga, E. A. L., Johnson, E., Temesgen, Z., Theiler, R., Gray, C. M., & Chakraborty, R. (2023). Prevention of the Vertical Transmission of HIV; A Recap of the Journey so Far. Viruses, 15(4), 849. https://doi.org/10.3390/v15040849
Vancouver
Cardenas MC, Farnan S, Hamel BL, Mejia Plazas MC, Sintim-Aboagye E, Littlefield DR, et al. Prevention of the Vertical Transmission of HIV; A Recap of the Journey so Far. Viruses. 2023;15(4):849. doi:10.3390/v15040849
BibTeX
@article{Cardenas2023,
author = {Cardenas, Maria Camila and Farnan, Sheila and Hamel, Benjamin L and Mejia Plazas, Maria Camila and Sintim-Aboagye, Elise and Littlefield, Dawn R and Behl, Supriya and Punia, Sohan and Enninga, Elizabeth Ann L and Johnson, Erica and Temesgen, Zelalem and Theiler, Regan and Gray, Clive M and Chakraborty, Rana},
title = {Prevention of the Vertical Transmission of HIV; A Recap of the Journey so Far},
journal = {Viruses},
year = {2023},
volume = {15},
number = {4},
pages = {849},
doi = {10.3390/v15040849}
}
EUVIMED